ImmunoCellular Therapeutics is actively seeking partnerships for the development and commercialization of its immunotherapy products. We believe our novel product candidates, strong intellectual property, proprietary discovery technology, and exclusive worldwide licensing agreement with Cedars-Sinai Medical center make us an attractive partnering candidate. We welcome inquiries from corporations, individuals, and academic institutions.

Current Partnerships

Progenitor Cell Therapy
Torrey Pines Institute for Molecular Studies
Cedars-Sinai Medical Center
George Mason University
University of Pennsylvania
MD Anderson Cancer Center